"
Team:Brasil-SP/Project/ResponseModule
From 2014.igem.org
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | |||
{{:Team:Brasil-SP/Templates/Header}} | {{:Team:Brasil-SP/Templates/Header}} | ||
| Line 7: | Line 6: | ||
<p><div align="justify"> The reporter gene chosen for the output system was the GFP. The main reason for that choice was the simplicity in measuring its fluorescenchttps://2014.igem.org/Main_Pagee with the fluorimeter and flow cytometry, but it can be replaced by any other reporter system. In the final development stage of the project we envision a output that do not need to be excited like the GFP does.</p> | <p><div align="justify"> The reporter gene chosen for the output system was the GFP. The main reason for that choice was the simplicity in measuring its fluorescenchttps://2014.igem.org/Main_Pagee with the fluorimeter and flow cytometry, but it can be replaced by any other reporter system. In the final development stage of the project we envision a output that do not need to be excited like the GFP does.</p> | ||
| - | <img src="https://static.igem.org/mediawiki/2014/0/0e/Circuit_response.png" width="500" height="370"/> | + | <div align="center"><img src="https://static.igem.org/mediawiki/2014/0/0e/Circuit_response.png" width="500" height="370"/></div> |
| - | <img src="https://static.igem.org/mediawiki/2014/3/34/Indicator.png" width="400" height"240"/> | + | <div align="center"><img src="https://static.igem.org/mediawiki/2014/3/34/Indicator.png" width="400" height"240"/></div> |
<p><div align="justify"> Note that the biossensor will perform a negative detection. In other words, when the patient is healthy we'll have no fluorescence, and when in a unhealthy situation the bacteria will not glow. In a more realistic approach, we do not expect our system to have only two intensities (zero or maximum glow). What might happen is that we'll have a more continuous spectrum of intensities, which would make it harder to differentiate between a negative and positive diagnosis. To deal with this problem we are adding a negative control in our <a href="https://2014.igem.org/Team:Brasil-SP/Results/Microfluidics">microfluidic device</a>. In this negative chamber there will be no blood serum in contact with our bacteria, therefore cathepsin S will work at full potencial generating a maximum LasR production and consequently maximum fluorescence.<p> | <p><div align="justify"> Note that the biossensor will perform a negative detection. In other words, when the patient is healthy we'll have no fluorescence, and when in a unhealthy situation the bacteria will not glow. In a more realistic approach, we do not expect our system to have only two intensities (zero or maximum glow). What might happen is that we'll have a more continuous spectrum of intensities, which would make it harder to differentiate between a negative and positive diagnosis. To deal with this problem we are adding a negative control in our <a href="https://2014.igem.org/Team:Brasil-SP/Results/Microfluidics">microfluidic device</a>. In this negative chamber there will be no blood serum in contact with our bacteria, therefore cathepsin S will work at full potencial generating a maximum LasR production and consequently maximum fluorescence.<p> | ||
Revision as of 16:43, 13 October 2014
Response Module
The reporter gene chosen for the output system was the GFP. The main reason for that choice was the simplicity in measuring its fluorescenchttps://2014.igem.org/Main_Pagee with the fluorimeter and flow cytometry, but it can be replaced by any other reporter system. In the final development stage of the project we envision a output that do not need to be excited like the GFP does.
Note that the biossensor will perform a negative detection. In other words, when the patient is healthy we'll have no fluorescence, and when in a unhealthy situation the bacteria will not glow. In a more realistic approach, we do not expect our system to have only two intensities (zero or maximum glow). What might happen is that we'll have a more continuous spectrum of intensities, which would make it harder to differentiate between a negative and positive diagnosis. To deal with this problem we are adding a negative control in our microfluidic device. In this negative chamber there will be no blood serum in contact with our bacteria, therefore cathepsin S will work at full potencial generating a maximum LasR production and consequently maximum fluorescence.
